» Articles » PMID: 39766326

Anesthetic- and Analgesic-Related Drugs Modulating Both Voltage-Gated Na and TRP Channels

Overview
Journal Biomolecules
Publisher MDPI
Date 2025 Jan 8
PMID 39766326
Authors
Affiliations
Soon will be listed here.
Abstract

Nociceptive information is transmitted by action potentials (APs) through primary afferent neurons from the periphery to the central nervous system. Voltage-gated Na channels are involved in this AP production, while transient receptor potential (TRP) channels, which are non-selective cation channels, are involved in receiving and transmitting nociceptive stimuli in the peripheral and central terminals of the primary afferent neurons. Peripheral terminal TRP vanilloid-1 (TRPV1), ankylin-1 (TRPA1) and melastatin-8 (TRPM8) activation produces APs, while central terminal TRP activation enhances the spontaneous release of L-glutamate from the terminal to spinal cord and brain stem lamina II neurons that play a pivotal role in modulating nociceptive transmission. There is much evidence demonstrating that chemical compounds involved in Na channel (or nerve AP conduction) inhibition modify TRP channel functions. Among these compounds are local anesthetics, anti-epileptics, α-adrenoceptor agonists, antidepressants (all of which are used as analgesic adjuvants), general anesthetics, opioids, non-steroidal anti-inflammatory drugs and plant-derived compounds, many of which are involved in antinociception. This review mentions the modulation of Na channels and TRP channels including TRPV1, TRPA1 and TRPM8, both of which modulations are produced by pain-related compounds.

References
1.
Kalso , TRAMER , McQuay , Moore . Systemic local-anaesthetic-type drugs in chronic pain: a systematic review. Eur J Pain. 2000; 2(1):3-14. DOI: 10.1016/s1090-3801(98)90041-6. View

2.
Matsushita A, Ohtsubo S, Fujita T, Kumamoto E . Inhibition by TRPA1 agonists of compound action potentials in the frog sciatic nerve. Biochem Biophys Res Commun. 2013; 434(1):179-84. DOI: 10.1016/j.bbrc.2013.02.127. View

3.
Hwang S, Burette A, Rustioni A, Valtschanoff J . Vanilloid receptor VR1-positive primary afferents are glutamatergic and contact spinal neurons that co-express neurokinin receptor NK1 and glutamate receptors. J Neurocytol. 2004; 33(3):321-9. DOI: 10.1023/B:NEUR.0000044193.31523.a1. View

4.
Premkumar L . Transient receptor potential channels as targets for phytochemicals. ACS Chem Neurosci. 2014; 5(11):1117-30. PMC: 4240255. DOI: 10.1021/cn500094a. View

5.
Grudt T, Williams J . mu-Opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat. J Neurosci. 1994; 14(3 Pt 2):1646-54. PMC: 6577538. View